ANANDRON
ANANDRON
Dormant
DIN Number
02221861
Drug Class
Human
Market Date
Aug 20, 1997
Company
HC
Cheplapharm Arzneimittel Gmbh
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02221861
AIG Number0121993001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L02BB02 NILUTAMIDE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification10:00.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
NILUTAMIDEActive
Strength: 50 MG
Monograph: NILUTAMIDE